Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3835959 | SEMERGEN - Medicina de Familia | 2007 | 11 Pages |
Abstract
If the symptoms predominate, we treat the patient pharmacologically with alpha blockers and if the progression factors of BPH predominate, we treat the patient with 5-alphareductase inhibitors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
F.J. Brenes Bermúdez, N. Pérez León, M. Pimienta Escrihuela, J.M. Dios Diz,